Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: A QSAR study

Molecular Pharmaceutics

Volumn 6, Issue 3, 2009, Pages 849-860

  Hansch, Corwin ^a   Verma, Rajeshwar P ^a  

^a POMONA COLLEGE   (United States)

Author keywords

tubulin; Cephalomannines; Drug resistant; Hydrophobicity; Molar refractivity; QSAR

Indexed keywords

BETA TUBULIN; CEPHALOMANNINE; GLYCOPROTEIN P;

ARTICLE; BINDING AFFINITY; CANCER RESISTANCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; HYDROPHOBICITY; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TAXOIDS; TUBULIN;

EID: 67249108708     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp800138w     Document Type: Article

References (66)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. Ca Cancer J. Clin. 2008, 58, 71-96.
2. Rowinsky, E. K.; Tolcher, A. W. Antimicrotubule Agents. In Cancer Principles and Practice of Oncology; DeVita, V. T. J., Hellman, S., Rosenberg, S. A., Eds.; Lippincott, Williams and Wilkins: Philadelphia, PA, 2001; pp 431-447.
3. Verma, R. P.; Hansch, C. Taxane analogues against breast cancer: a quantitative structure-activative relationship study. ChemMedChem 2008, 3, 642-652.
4. Roh, E. J.; Kim, D.; Lee, C. O.; Choi, S. U.; Song, C. E. Structure-activity relationship study at the 3′-N-position of paclitaxel: Synthesis and biological evaluation of 3′-N-acylpaclitaxel analogues. Bioorg. Med. Chem. 2002, 10, 3145-3151. (Pubitemid 34855388)
5. Ojima, I.; Slater, J. C.; Kuduk, S. D.; Takeuchi, C. S.; Gimi, R. H.; Sun, C.-M.; Park, Y. H.; Pera, P.; Veith, J. M.; Bernacki, R. J. Syntheses and Structure-Activity Relationships of Taxoids Derived from 14β-Hydroxy-10- deacetylbaccatin III. J. Med. Chem. 1997, 40, 267-278. (Pubitemid 27081961)
6. Arbuck, S. G.; Blaylock, B. A. Taxol: Clinical Results and Current Issues in Development. In Taxol: Science and Applications; Suffness, M., Ed.; CRC Press: Boca Raton, FL, 1995; pp 379- 415.
7. Hansch, C.; Verma, R. P. Understanding tubulin/microtubuletaxane interactions: A Quantitative Structure-Activity Relationship Study. Mol. Pharmaceutics 2008, 5, 151-161. (Pubitemid 351300044)
8. Wang, T.-H.; Wang, H.-S.; Song, Y.-K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 2000, 88, 2619-2628. (Pubitemid 30331971)
9. Blagosklonny, M. V.; Fojo, T. Molecular effects of paclitaxel: myths and reality (a critical review). Int. J. Cancer 1999, 83, 151-156. (Pubitemid 29449089)
10. Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of microtubule assembly in vitro by taxol. Nature (London) 1979, 277, 665-667. (Pubitemid 9114288)
11. Galletti, E.; Magnani, M.; Renzulli, M. L.; Botta, M. Paclitaxel and docetaxel resistance: Molecular mechanisms and development of new generation taxanes. ChemMedChem 2007, 2, 920-942.
12. Kuppens, I. E. L. M. Current state of the art of new tubulin inhibitors in the clinic. Curr. Clin. Pharmacol. 2006, 1, 57-70.
13. He, L.; Orr, G. A.; Horwitz, S. B. Novel molecules that interact with microtubules and have functional activity similar to taxol. DDT 2001, 6, 1153-1164. (Pubitemid 32999054)
14. Pineda, O.; Farra's, J.; Maccari, L.; Manetti, F.; Botta, M.; Vilarrasa, J. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine. Bioorg. Med. Chem. Lett. 2004, 14, 4825-4829.
15. Miller, R. W.; Powell, R. G.; Smith, C. R., Jr.; Arnold, E.; Clardy, J. Antileukemic Alkaloids from Taxus wallichiana Zucc. J. Org. Chem. 1981, 46, 1469-1474. (Pubitemid 11122273)
16. Baloglu, E.; Hoch, J. M.; Chatterjee, S. K.; Ravindra, R.; Bane, S.; Kingston, D. G. I. Synthesis and biological evaluation of C-3′NH/C-10 and C-2/C-10 modified paclitaxel analogues. Bioorg. Med. Chem. 2003, 11, 1557-1568. (Pubitemid 36293547)
17. Hansch, C.; Maloney, P. P.; Fujita, T.; Muir, R. M. Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients. Nature (London) 1962, 194, 178-180.
18. Hansch, C.; Leo, A. In Exploring QSAR: Fundamentals and Applications in Chemistry and Biology; American Chemical Society: Washington, DC, 1995.
19. Bermudez-Saldana, J. M.; Cronin, M. T. D. Quantitative structure-activity relationships for the toxicity of organophosphorus and carbamate pesticides to the rainbow trout Onchorhynchus mykiss. Pest Manage. Sci. 2006, 62, 819-831. (Pubitemid 44342185)
20. Hansch, C.; Telzer, B. R.; Zhang, L. Comparative QSAR in toxicology: examples from teratology and cancer chemotherapy of aniline mustards. Crit. Rev. Toxicol. 1995, 25, 67-89.
21. Schultz, T. W.; Hewitt, M.; Netzeva, T. I.; Cronin, M. T. D. Assessing applicability domains of toxicological QSARs: definition, confidence in predicted values, and the role of mechanisms of action. QSAR Comb. Sci. 2007, 26, 238-254. (Pubitemid 46931735)
22. Selassie, C. D.; Garg, R.; Kapur, S.; Kurup, A.; Verma, R. P.; Mekapati, S. B.; Hansch, C. Comparative QSAR and the Radical Toxicity of Various Functional Groups. Chem. Rev. 2002, 102, 2585-2605.
23. Winkler, D. A. The role of quantitative structure-activity relationships (QSAR) in biomolecular discovery. Briefings Bioinf. 2002, 3, 73-86.
24. Verma, R. P.; Hansch, C. Matrix metalloproteinases (MMPs): Chemical-biological functions and QSARs. Bioorg. Med. Chem. 2007, 15, 2223-2268. (Pubitemid 46240907)
25. Fujikawa, M.; Nakao, K.; Shimizu, R.; Akamatsu, M. QSAR study on permeability of hydrophobic compounds with artificial membranes. Bioorg. Med. Chem. 2007, 15, 3756-3767. (Pubitemid 46635142)
26. Verma, R. P.; Hansch, C.; Selassie, C. D. Comparative QSAR studies on PAMPA/modified PAMPA for high throughput profiling of drug absorption potential with respect to Caco-2 cells and human intestinal absorption. J. Comput.-Aided. Mol. Des. 2007, 21, 3-22. (Pubitemid 46416663)
27. Kodithala, K.; Hopfinger, A. J.; Thompson, E. D.; Robinson, M. K. Prediction of skin irritation from organic chemicals using membrane - interaction QSAR analysis. Toxicol. Sci. 2002, 66, 336-346. (Pubitemid 34285129)
28. Verma, R. P. Cytotoxicity of heterocyclic compounds against various cancer cells: a quantitative structure-activity relationship study. Top. Heterocycl. Chem. 2007, 9, 53-86.
29. Garg, R.; Gupta, S. P.; Gao, H.; Babu, M. S.; Debnath, A. K.; Hansch, C. Comparative Quantitative Structure-Activity Relationship Studies on Anti-HIV Drugs. Chem. Rev. 1999, 99, 3525-3601. (Pubitemid 129589128)
30. Verma, R. P.; Hansch, C. Combating the Threat of Anthrax: A Quantitative Structure-Activity Relationship Approach. Mol. Pharmaceutics 2008, 5, 745-759.
31. Verma, R. P.; Kurup, A.; Mekapati, S. B.; Hansch, C. Chemical-biological interactions in human. Bioorg. Med. Chem. 2005, 13, 933-948. (Pubitemid 40164580)
32. Hall, L. H.; Hall, L. M. QSAR modeling based on structure-information for properties of interest in human health. SAR QSAR Environ. Res. 2005, 16, 13-41. (Pubitemid 40623241)
33. Hansch, C.; Leo, A.; Mekapati, S. B.; Kurup, A. QSAR and ADME. Bioorg. Med. Chem. 2004, 12, 3391-3400.
34. Khan, M. T. H.; Sylte, I. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules. Curr. Drug Discovery Technol. 2007, 4, 141-149. (Pubitemid 350171816)
35. Selassie, C. D.; Mekapati, S. B.; Verma, R. P. QSAR: then and now. Curr. Top. Med. Chem. 2002, 2, 1357-1379.
36. Yang, C.-G.; Barasoain, I.; Li, X.; Matesanz, R.; Liu, R.; Sharom, F. J.; Yin, D.-L.; Díaz, J. F.; Fang, W.-S. Overcoming tumor drug resistance with high-affinity taxanes: A SAR study of C2-modified 7-acyl-10-deacetyl cephalomannines. ChemMedChem 2007, 2, 691-701.
37. C-QSAR Program; BioByte Corp.: Claremont, CA; www. biobyte.com
38. Hansch, C.; Hoekman, D.; Leo, A.; Weininger, D.; Selassie, C. D. Chem-Bioinformatics: Comparative QSAR at the Interface between Chemistry and Biology. Chem. Rev. 2002, 102, 783-812.
39. Verma, R. P.; Hansch, C. Development of QSAR models using C-QSAR program: a regression program that has dual databases of over 21,000 QSAR models. Nat. Protoc., http://dx.doi.org/ 10.1038/nprot.2007.125.
40. Lorentz, H. A. The Theory of Electrons, 2nd ed.; Dover: New York, 1952.
41. Partington, J. R. An Advanced Treatise on Physical Chemistry; Longmans, Green & Co. Ltd: New York, 1953; Vol.IV: Physico- Chemical Properties.
42. Selassie, C. D. In Burger's Medicinal Chemistry and Drug Descovery: History of Quantitative Structure-Activity Relationships, 6th ed.; Abraham, D. J., Ed.; John Wiley & Sons: New York, 2003; Vol.1: Drug Discovery.
43. Cramer, R. D., III.; Bunce, J. D.; Patterson, D. E.; Frank, I. E. Cross validation, Bootstrapping and partial least squares compared with multiple regression in conventional QSAR studies. Quant. Struct.-Act. Relat. 1988, 7, 18-25.
44. Bennett, C. A.; Franklin, N. L. Statistical Analysis in Chemistry and the Chemical Industry. John Wiley & Sons: New York, 1967; pp 708-709; 5th printing.
45. Pogliani, L. Modeling with Special Descriptors Derived from a Medium-Sized Set of Connectivity Indices. J. Phys. Chem. 1996, 100, 18065-18077. (Pubitemid 126788760)
46. Pogliani, L. From Molecular Connectivity Indices to Semiempirical Connectivity Terms: Recent Trends in Graph Theoretical Descriptors. Chem. Rev. 2000, 100, 3827-3858. (Pubitemid 30964980)
47. Selassie, C. D.; Kapur, S.; Verma, R. P.; Rosario, M. Cellular Apoptosis and Cytotoxicity of Phenolic Compounds: A Quantitative Structure-Activity Relationship Study. J. Med. Chem. 2005, 48, 7234-7242. (Pubitemid 41743637)
48. Verma, R. P.; Hansch, C. Cytotoxicity of Organic Compounds against Ovarian Cancer Cells: A Quantitative Structure-Activity Relationship Study. Mol. Pharmaceutics 2006, 3, 441-450. (Pubitemid 44351927)
49. Verma, R. P.; Hansch, C. Understanding human rhinovirus infections in terms of QSAR. Virology 2007, 359, 152-161. (Pubitemid 46215700)
50. Hansch, C.; Verma, R. P. 20-(S)-Camptothecin analogues as DNA topoisomerase I inhibitors: A QSAR study. ChemMedChem 2007, 2, 1807-1813.
51. Verma, R. P.; Hansch, C. Investigation of DNA-binding properties of organic molecules using quantitative structure-activity relationship (QSAR) models. J. Pharm. Sci. 2008, 97, 88-110.
52. Verma, R. P.; Hansch, C. An approach toward the problem of outliers in QSAR. Bioorg. Med. Chem. 2005, 13, 4597-4621. (Pubitemid 40848339)
53. Polanski, J.; Bak, A.; Gieleciak, R.; Magdziarz, T. Modeling Robust QSAR. J. Chem. Inf. Model. 2006, 46, 2310-2318.
54. Ekins, S.; Mestres, J.; Testa, B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br. J. Pharmacol. 2007, 152, 9-20. (Pubitemid 47339896)
55. Snyder, J. P.; Nettles, J. H.; Cornett, B.; Downing, K. H.; Nogales, E. The binding conformation of Taxol in β-tubulin: A model based on electron crystallographic density. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 5312-5316. (Pubitemid 32397125)
56. Jaworska, J. S.; Comber, M.; Auer, C.; Van Leeuwen, C. J. Summary of workshop on regulatory acceptance of (Q)SARs for human health and environmental endpoints. Environ. Health Perspect. 2003, 111, 1358-1360. (Pubitemid 37021141)
57. Eriksson, L.; Jaworska, J.; Worth, A. P.; Cronin, M. T. D.; McDowell, R. M.; Gramatica, P. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ. Health Perspect. 2003, 111, 1361-1375. (Pubitemid 37021142)
58. Cronin, M. T. D.; Walker, J. D.; Jaworska, J. S.; Comber, M. H. I.; Watts, C. D.; Worth, A. P. Use of QSARs in international decision-making frameworks to predict ecologic effects and environmental fate of chemical substances. Environ. Health Perspect. 2003, 111, 1376-1390. (Pubitemid 37021143)
59. Cronin, M. T. D.; Jaworska, J. S.; Walker, J. D.; Comber, M. H. I.; Watts, C. D.; Worth, A. P. Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environ. Health Perspect. 2003, 111, 1391-1401. (Pubitemid 37021144)
60. 2! J. Mol. Graphics Modell. 2002, 20, 269-276.
61. Tropsha, A.; Gramatica, P.; Gombar, V. K. The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb. Sci. 2003, 22, 69-77. (Pubitemid 36717473)
62. Wold, S.; Eriksson, L. In Chemometrics Methods in Molecular Design: Statistical Validation of QSAR Results; van de Waterbeemd, H., Ed.; VCH: Weinheim, Germany, 1995; pp 309-318.
63. Melzig, M. F.; Tran, G. D.; Henke, K.; Selassie, C. D.; Verma, R. P. Inhibition of neutrophil elastase and thrombin activity by caffeic acid esters. Pharmazie 2005, 60, 869-873. (Pubitemid 41704167)
64. Zhang, S.; Golbraikh, A.; Oloff, S.; Kohn, H.; Tropsha, A. A novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models. J. Chem. Inf. Model. 2006, 46, 1984-1995. (Pubitemid 44625970)
65. Kingston, D. G. I.; Chaudhary, A. G.; Chordia, M. D.; Gharpure, M.; Gunatilaka, A. A. L.; Higgs, P. I.; Rimoldi, J. M.; Samala, L.; Jagtap, P. G.; Giannakakou, P.; Jiang, Y. Q.; Lin, C. M.; Hamel, E.; Long, B. H.; Fairchild, C. R.; Johnston, K. A. Synthesis and Biological Evaluation of 2-Acyl Analogues of Paclitaxel (Taxol). J. Med. Chem. 1998, 41, 3715-3726. (Pubitemid 28449354)
66. Chaudhary, A. G.; Gharpure, M. M.; Rimoldi, J. M.; Chordia, M. D.; Kingston, D. G. I.; Grover, S.; Lin, C. M.; Hamel, E.; Gunatilaka, A. A. L. Unexpectedly Facile Hydrolysis of the 2-Benzoate Group of Taxol and Syntheses of Analogs with Increased Activities. J. Am. Chem. Soc. 1994, 116, 4097-4098. (Pubitemid 24183891)